Cargando…
Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation
BACKGROUND: Antiretroviral (ARV) medicines reduce the risk of transmitting the HIV virus and are recommended as daily pre-exposure prophylaxis (PrEP) in combination with safer sex practices for HIV-negative individuals at a high risk for infection, but are underused in HIV prevention. Previous liter...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842325/ https://www.ncbi.nlm.nih.gov/pubmed/29467119 http://dx.doi.org/10.2196/publichealth.7733 |
_version_ | 1783304878844542976 |
---|---|
author | Kecojevic, Aleksandar Basch, Corey Basch, Charles Kernan, William |
author_facet | Kecojevic, Aleksandar Basch, Corey Basch, Charles Kernan, William |
author_sort | Kecojevic, Aleksandar |
collection | PubMed |
description | BACKGROUND: Antiretroviral (ARV) medicines reduce the risk of transmitting the HIV virus and are recommended as daily pre-exposure prophylaxis (PrEP) in combination with safer sex practices for HIV-negative individuals at a high risk for infection, but are underused in HIV prevention. Previous literature suggests that YouTube is extensively used to share health information. While pre-exposure prophylaxis (PrEP) is a novel and promising approach to HIV prevention, there is limited understanding of YouTube videos as a source of information on PrEP. OBJECTIVE: The objective of this study was to describe the sources, characteristics, and content of the most widely viewed PrEP YouTube videos published up to October 1, 2016. METHODS: The keywords “pre-exposure prophylaxis” and “Truvada” were used to find 217 videos with a view count >100. Videos were coded for source, view count, length, number of comments, and selected aspects of content. Videos were also assessed for the most likely target audience. RESULTS: The total cumulative number of views was >2.3 million, however, a single Centers for Disease Control and Prevention video accounted for >1.2 million of the total cumulative views. A great majority (181/217, 83.4%) of the videos promoted the use of PrEP, whereas 60.8% (132/217) identified the specific target audience. In contrast, only 35.9% (78/217) of the videos mentioned how to obtain PrEP, whereas less than one third addressed the costs, side effects, and safety aspects relating to PrEP. Medical and academic institutions were the sources of the largest number of videos (66/217, 30.4%), followed by consumers (63/217, 29.0%), community-based organizations (CBO; 48/217, 22.1%), and media (40/217, 18.4%). Videos uploaded by the media sources were more likely to discuss the cost of PrEP (P<.001), whereas the use of PrEP was less likely to be promoted in videos uploaded by individual consumers (P=.002) and more likely to be promoted in videos originated by CBOs (P=.009). The most common target audience for the videos was gay and bisexual men. CONCLUSIONS: YouTube videos can be used to share reliable PrEP information with individuals. Further research is needed to identify the best practices for using this medium to promote and increase PrEP uptake. |
format | Online Article Text |
id | pubmed-5842325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58423252018-03-09 Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation Kecojevic, Aleksandar Basch, Corey Basch, Charles Kernan, William JMIR Public Health Surveill Original Paper BACKGROUND: Antiretroviral (ARV) medicines reduce the risk of transmitting the HIV virus and are recommended as daily pre-exposure prophylaxis (PrEP) in combination with safer sex practices for HIV-negative individuals at a high risk for infection, but are underused in HIV prevention. Previous literature suggests that YouTube is extensively used to share health information. While pre-exposure prophylaxis (PrEP) is a novel and promising approach to HIV prevention, there is limited understanding of YouTube videos as a source of information on PrEP. OBJECTIVE: The objective of this study was to describe the sources, characteristics, and content of the most widely viewed PrEP YouTube videos published up to October 1, 2016. METHODS: The keywords “pre-exposure prophylaxis” and “Truvada” were used to find 217 videos with a view count >100. Videos were coded for source, view count, length, number of comments, and selected aspects of content. Videos were also assessed for the most likely target audience. RESULTS: The total cumulative number of views was >2.3 million, however, a single Centers for Disease Control and Prevention video accounted for >1.2 million of the total cumulative views. A great majority (181/217, 83.4%) of the videos promoted the use of PrEP, whereas 60.8% (132/217) identified the specific target audience. In contrast, only 35.9% (78/217) of the videos mentioned how to obtain PrEP, whereas less than one third addressed the costs, side effects, and safety aspects relating to PrEP. Medical and academic institutions were the sources of the largest number of videos (66/217, 30.4%), followed by consumers (63/217, 29.0%), community-based organizations (CBO; 48/217, 22.1%), and media (40/217, 18.4%). Videos uploaded by the media sources were more likely to discuss the cost of PrEP (P<.001), whereas the use of PrEP was less likely to be promoted in videos uploaded by individual consumers (P=.002) and more likely to be promoted in videos originated by CBOs (P=.009). The most common target audience for the videos was gay and bisexual men. CONCLUSIONS: YouTube videos can be used to share reliable PrEP information with individuals. Further research is needed to identify the best practices for using this medium to promote and increase PrEP uptake. JMIR Publications 2018-02-16 /pmc/articles/PMC5842325/ /pubmed/29467119 http://dx.doi.org/10.2196/publichealth.7733 Text en ©Aleksandar Kecojevic, Corey Basch, Charles Basch, William Kernan. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 16.02.2018. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on http://publichealth.jmir.org, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Kecojevic, Aleksandar Basch, Corey Basch, Charles Kernan, William Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation |
title | Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation |
title_full | Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation |
title_fullStr | Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation |
title_full_unstemmed | Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation |
title_short | Pre-Exposure Prophylaxis YouTube Videos: Content Evaluation |
title_sort | pre-exposure prophylaxis youtube videos: content evaluation |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842325/ https://www.ncbi.nlm.nih.gov/pubmed/29467119 http://dx.doi.org/10.2196/publichealth.7733 |
work_keys_str_mv | AT kecojevicaleksandar preexposureprophylaxisyoutubevideoscontentevaluation AT baschcorey preexposureprophylaxisyoutubevideoscontentevaluation AT baschcharles preexposureprophylaxisyoutubevideoscontentevaluation AT kernanwilliam preexposureprophylaxisyoutubevideoscontentevaluation |